Parkside Financial Bank & Trust’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-107
Closed -$1.65K 2716
2025
Q4
$1.65K Buy
107
+57
+114% +$628 ﹤0.01% 2168
2025
Q3
$497 Hold
50
﹤0.01% 2576
2025
Q2
$496 Sell
50
-546
-92% -$5.75K ﹤0.01% 2560
2025
Q1
$7.73K Buy
596
+560
+1,556% +$7.41K ﹤0.01% 1499
2024
Q4
$460 Hold
36
﹤0.01% 1888
2024
Q3
$402 Sell
36
-7
-16% -$77 ﹤0.01% 1873
2024
Q2
$483 Buy
43
+29
+207% +$338 ﹤0.01% 1781
2024
Q1
$174 Sell
14
-12
-46% -$157 ﹤0.01% 1965
2023
Q4
$364 Sell
26
-154
-86% -$2.14K ﹤0.01% 1811
2023
Q3
$2.66K Hold
180
﹤0.01% 1573
2023
Q2
$2.33K Buy
180
+14
+8% +$160 ﹤0.01% 1645
2023
Q1
$1.63K Sell
166
-91
-35% -$971 ﹤0.01% 1754
2022
Q4
$2.73K Buy
257
+248
+2,756% +$2.88K ﹤0.01% 1574
2022
Q3
$0 Sell
9
-234
-96% -$3.05K ﹤0.01% 1825
2022
Q2
$3K Buy
+243
New +$2.58K ﹤0.01% 1422

Other funds holding DVAX

Parkside Financial Bank & Trust's DVAX Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 107 shares — an estimated $1.65K sold.

Parkside Financial Bank & Trust first reported a position in DVAX in Q2 2022 and held it in 15 quarters. The position peaked at $7.73K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 107 Dynavax Technologies shares in Q1 2026, an estimated $1.65K.
  • Parkside Financial Bank & Trust first reported a position in Dynavax Technologies in Q2 2022 and held it in 15 quarters.
  • Parkside Financial Bank & Trust's Dynavax Technologies position peaked at $7.73K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.